De. Semler et al., ENDOTHELIN-1-EVOKED CALCIUM TRANSIENTS IN UMR-106 OSTEOBLASTIC OSTEOSARCOMA CELLS ARE MEDIATED THROUGH ENDOTHELIN-A AND ENDOTHELIN-B RECEPTORS, The Journal of pharmacology and experimental therapeutics, 272(3), 1995, pp. 1052-1058
Endothelin (ET) receptor subtypes involved in the modulation of intrac
ellular calcium were studied in UMR-106 osteoblastic osteosarcoma cell
s. Calcium signaling in UMR-106 cells in suspension was determined wit
h fluo-3-acetoxymethylester fluorescent dye. ET-1 and the ET(B)-select
ive agonist sarafotoxin 6c (S6c) elicited rapid calcium transients, Ma
ximally effective concentrations of the ET(A)-selective antagonist BQ-
123 [Cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu)] attenuated ET-1-evoked calcium
transients by only 50%. BQ-123 had no effect on S6c-stimulated transi
ents. ET-1 and S6c showed homologous desensitization on repeated admin
istration. Pretreatment with ET-1 completely eliminated S6c-evoked cal
cium transients, whereas S6c pretreatment only partially (50%) attenua
ted the calcium transient evoked by ET-1. Joint pretreatment with S6c
and BQ-123 or pretreatment with the ET(A)/ET(B) nonselective antagonis
t PD-142893 (Ac-D-diphenylalanine-Leu-Asp-Ile-Ile-Trp) eliminated the
ET-1-stimulated calcium transient, These cells display both ET(A) and
ET(B) receptors (60:40), as demonstrated by saturation binding experim
ents with [I-125] ET-1 and the ET(B) specific agonist, [I-125] IRL-162
0 (SUc [Glu(9), Ala(11,15)] endothelin-1 [8-21]), This was further con
firmed by competition binding experiments using [I-125] ET-1 and subty
pe-selective ligands S6c and BQ-123. These data indicate that ET-1 int
eracts with both ET(A) and ET(B) receptors to elicit calcium transient
s in UMR-IOB osteoblastic osteosarcoma cells.